Sandy Macrae - 22 Jan 2025 Form 4 Insider Report for SANGAMO THERAPEUTICS, INC (SGMO)

Role: PRESIDENT, CEO AND DIRECTOR, Director
Signature: /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol: SGMO
Transactions as of: 22 Jan 2025
Net transactions value: -$474,472
Form type: 4
Filing time: 24 Jan 2025, 16:05:10 UTC
Previous filing: 26 Nov 2024
Next filing: 26 Feb 2025
SEC: View on sec.gov

Key filing fact

Sandy Macrae filed Form 4 for SANGAMO THERAPEUTICS, INC (SGMO) on 24 Jan 2025.

Key facts

This page summarizes Sandy Macrae's Form 4 filing for SANGAMO THERAPEUTICS, INC (SGMO).
1 reported transaction and 0 derivative rows are listed below.
Filing timestamp: 24 Jan 2025, 16:05.

Change

Previous filing in this sequence was filed on 26 Nov 2024.
Current net transaction value: -$474,472.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

SGMO transaction

Common Stock

Tax liability

Transaction value: $474,472
Shares: -412,584
Change %: -16%
Price: $1.15
Shares after: 2,095,999
Date: 22 Jan 2025
Ownership: Direct
Footnotes: F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares underlying the portion of a restricted stock unit ("RSU") grant that vested on January 22, 2025, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on January 22, 2025 of $1.15/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise.
F2	Includes: (a) 587,416 shares resulting from the January 22, 2025 vesting installment of the Reporting Person's January 22, 2024 RSU grant, and the remaining 1,000,000 shares will vest in successive equal quarterly installments through January 22, 2026, (b) 21,000 shares subject to the Reporting Person's February 25, 2022 RSU grant that will vest in one final installment on February 25, 2025 and (c) 73,735 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest in successive equal quarterly installments through February 24, 2026. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.

Content

Represents shares underlying the portion of a restricted stock unit ("RSU") grant that vested on January 22, 2025, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on January 22, 2025 of $1.15/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise.

Includes: (a) 587,416 shares resulting from the January 22, 2025 vesting installment of the Reporting Person's January 22, 2024 RSU grant, and the remaining 1,000,000 shares will vest in successive equal quarterly installments through January 22, 2026, (b) 21,000 shares subject to the Reporting Person's February 25, 2022 RSU grant that will vest in one final installment on February 25, 2025 and (c) 73,735 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest in successive equal quarterly installments through February 24, 2026. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.